Cue Biopharma Announces PLOS One Publication Demonstrating the Generation and Evaluation of Novel Molecules with Directed Mutations within the B7 Superfamily

NEXT STORY
Atreca and Xencor Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies
PREV STORY
Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimer’s Disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Cue Biopharma Announces PLOS One Publication Demonstrating the Generation and Evaluation of Novel Molecules with Directed Mutations within the B7 Superfamily

NEXT STORY
Atreca and Xencor Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies
PREV STORY
Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimer’s Disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Announces Two New Publications from the Positive Phase 2 FILLY Study Evaluating Pegcetacoplan in Geographic Atrophy

author_avatar
NASDAQ Market News

American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure

ROCKVILLE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), ...

author_avatar
NASDAQ Market News

Chimerix Announces Third Quarter 2018 Financial Results

- Conference Call at 8:30 a.m. ET Today - DURHAM, N.C., Nov. 08, 2018 ...

author_avatar
NASDAQ Market News